DK0540525T3 - Fremgangsmåde til fremstilling af vacciner og anvendelse af de således fremstillede vacciner - Google Patents

Fremgangsmåde til fremstilling af vacciner og anvendelse af de således fremstillede vacciner

Info

Publication number
DK0540525T3
DK0540525T3 DK91909986T DK91909986T DK0540525T3 DK 0540525 T3 DK0540525 T3 DK 0540525T3 DK 91909986 T DK91909986 T DK 91909986T DK 91909986 T DK91909986 T DK 91909986T DK 0540525 T3 DK0540525 T3 DK 0540525T3
Authority
DK
Denmark
Prior art keywords
lytic
gene
vaccines
proteins
partial sequences
Prior art date
Application number
DK91909986T
Other languages
English (en)
Inventor
Werner Lubitz
Original Assignee
Evax Tech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evax Tech Ag filed Critical Evax Tech Ag
Application granted granted Critical
Publication of DK0540525T3 publication Critical patent/DK0540525T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91909986T 1990-07-26 1991-05-24 Fremgangsmåde til fremstilling af vacciner og anvendelse af de således fremstillede vacciner DK0540525T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4023721A DE4023721A1 (de) 1990-07-26 1990-07-26 Verfahren zur herstellung von vakzinen und ihre verwendung
PCT/EP1991/000967 WO1992001791A1 (de) 1990-07-26 1991-05-24 Verfahren zur herstellung von vakzinen und ihre verwendung

Publications (1)

Publication Number Publication Date
DK0540525T3 true DK0540525T3 (da) 2000-04-03

Family

ID=6411039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909986T DK0540525T3 (da) 1990-07-26 1991-05-24 Fremgangsmåde til fremstilling af vacciner og anvendelse af de således fremstillede vacciner

Country Status (9)

Country Link
EP (1) EP0540525B1 (da)
JP (1) JP3329451B2 (da)
AT (1) ATE184915T1 (da)
AU (1) AU656525B2 (da)
DE (2) DE4023721A1 (da)
DK (1) DK0540525T3 (da)
IE (1) IE911843A1 (da)
NZ (1) NZ238303A (da)
WO (1) WO1992001791A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU2002314626B2 (en) 2001-06-11 2008-01-03 Applied Nanosystems B.V. Methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms
EP2255826B1 (en) 2002-08-02 2016-04-13 GlaxoSmithKline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens
JP5275983B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
JP5723768B2 (ja) 2008-05-30 2015-05-27 ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー オブ ジ アーミー， オン ビハーフ オブ ウォルター リード アーミー インスティチュート オブ リサーチ 髄膜炎菌性多価未変性外膜小胞ワクチン、その作製方法およびその使用
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
KR101825439B1 (ko) * 2016-04-15 2018-02-05 배재대학교 산학협력단 염산 처리에 의한 그람양성 박테리아 고스트의 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2143238A (en) * 1983-03-31 1985-02-06 Dr Anthony Stuart Breeze A method for enzyme liberation from bacterial cells
US4637980A (en) * 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
DE3715840A1 (de) * 1987-05-12 1988-12-01 Boehringer Mannheim Gmbh Fuer ein lytisch wirksames, chimaeres protein kodierende rekombinante dna und ihre verwendung
DE4005874A1 (de) * 1990-02-24 1991-11-07 Boehringer Mannheim Gmbh Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine

Also Published As

Publication number Publication date
NZ238303A (en) 1993-07-27
ATE184915T1 (de) 1999-10-15
AU656525B2 (en) 1995-02-09
WO1992001791A1 (de) 1992-02-06
DE59109155D1 (de) 1999-10-28
AU7894991A (en) 1992-02-18
EP0540525B1 (de) 1999-09-22
IE911843A1 (en) 1992-01-29
JP3329451B2 (ja) 2002-09-30
DE4023721A1 (de) 1992-01-30
JPH06501378A (ja) 1994-02-17
EP0540525A1 (de) 1993-05-12

Similar Documents

Publication Publication Date Title
KR100316004B1 (ko) Crm단백질및디프테리아독소의생산을위한방법및플라스미드
DK0786009T3 (da) Fremgangsmåde til bakteriel fremstilling af heterologe polypeptider med disulphidbindinger
DE69838383D1 (de) Kulturmedium mit sojabohnenextrakt als aminosäuren-quelle und ohne proteinkomplexe tierischen ursprungs
ES2196009T3 (es) Procedimiento para inmovilizar enzimas en la pared celular de una celula microbiana mediante la produccion de una proteina de fusion.
EP0400958A3 (en) Live vaccines
DE69535940D1 (de) Verfahren zur Herstellung von biologischen Produkten in Protein-freiem Kultur
NO179106C (no) Fremgangsmåte for fremstilling av og ekspresjonssystem som koder for og kan uttrykke et rekombinant proteinkompleks med humanfaktor V111:C-aktivitet
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
DK0540525T3 (da) Fremgangsmåde til fremstilling af vacciner og anvendelse af de således fremstillede vacciner
KR20030031979A (ko) 파아지를 이용한 생리 활성 단백질 및 펩티드의 대량생산법
CA2467801A1 (fr) Sequences nucleiques issues du genome de salmonella typhi, et leurs utilisations notamment pour le diagnostic in vitro de la presence de bacteries du genre salmonella dans les produits alimentaires
FI102189B1 (fi) Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämiseksi
DE59410401D1 (de) VERFAHREN ZUR HERSTELLUNG REKOMBINANTER PilC-PROTEINE
ES2003314A4 (es) Enzimas amiloliticas que producen microorganismos construidos por tecnologia adn recombinante y su uso para procedimientos de fermentacion.
JPS62163694A (ja) 宿生バチルス属微生物の異種構造形質転換方法
EA199600001A3 (ru) Агент экстракции периплазматических рекомбинантных белков, способ экстракции периплазматического белка и способ культивирования прокариотического микроорганизма
MY103364A (en) Synthetic porcine growth hormone
DE69633179D1 (de) Transferrinrezeptorgene
FI960951A (fi) Akarboosibiosynteesigeenejä Actinoplanes sp:stä, menetelmiä niiden eristämiseksi sekä niiden käyttö
ES2056410T3 (es) Procedimiento de produccion a partir de cepas de bacillus subtilis y procedimiento de preparacion de dichas cepas.
RU94030484A (ru) Плазмида, вектор, микроорганизм, лактобациллы, применение плазмиды и вектора
ATE167897T1 (de) Expressionsvektoren und verfahren zur herstellung intrazellularer proteine
PT742829E (pt) Expressao de proteinas heterologas em bacterias atenuadas utilizando os promotores htra
FR2244542A1 (en) Vaccines prepd from IB-RS-2- cells - for treatment of porcine pests
Weber Dynamics of plasmid-containing cells in a chemostat under transient conditions